# CarelonRx

> CarelonRx is Elevance Health’s U.S. pharmacy benefit management business. Created as IngenioRx in 2017 and renamed in 2023, it manages prescription benefits, drug lists, clinical reviews, pharmacy networks, and medication support for health plans and employers. Its approach connects medical and pharmacy information to address access, adherence, and total healthcare costs.

- **Founded:** 2017
- **Headquarters:** Morristown, United States
- **Founders:** Anthem, Inc. (now Elevance Health, Inc.) (Corporate founder)
- **Products:** Pharmacy benefit management, Rx Care Nexus, Utilization management, Specialty Condition Management, CarelonRx Pharmacy
- **Notable:** Began IngenioRx operations May 1, 2019, eight months earlier than originally planned., Reports more than 17.2 million members and 360 million annual prescriptions using 2024 internal data., Elevance reported 30% fewer inpatient admissions in a two-year evaluation of Medicaid members receiving CarelonRx/CPESN support; the result is program-specific and is not a universal guarantee.

## Products & services

- **Pharmacy benefit management** — Benefit design, formulary management, pharmacy networks, claims administration, and clinical cost-management services for plan sponsors.
- **Rx Care Nexus** — Identifies at-risk members and gaps involving adherence, safety, appropriate use, and lower-cost formulary alternatives.
- **Utilization management** — Prior authorization, step therapy, quantity limits, and dose optimization.
- **Specialty Condition Management** — Nurse support and education for people receiving specialty therapies and managing complex conditions.
- **CarelonRx Pharmacy** — Home delivery of eligible maintenance medications, supported by digital prescription tools and pharmacy assistance.
- **BioPlus Specialty Pharmacy** — Specialty dispensing and patient support for complex and chronic conditions; acquired in 2023.
- **CarelonRx mobile app** — Medication pricing, coverage checks, pharmacy search, order tracking, refill requests, payment, prescription history, and member-service chat.
- **Weight Management Program** — Behavior-based lifestyle and medication support where applicable; October 2026 enhancements include Noom-supported digital engagement.

## Achievements

- Began IngenioRx operations May 1, 2019, eight months earlier than originally planned.
- Reports more than 17.2 million members and 360 million annual prescriptions using 2024 internal data.
- Elevance reported 30% fewer inpatient admissions in a two-year evaluation of Medicaid members receiving CarelonRx/CPESN support; the result is program-specific and is not a universal guarantee.
- Reported full-year 2025 segment operating revenue of $43.4 billion.

## Latest updates

- **2026-10** — Weight Management Program enhancements were scheduled to launch October 1, including Noom-supported digital engagement and lifestyle support; the digital experience does not prescribe or dispense medication.
- **2026-09** — Published an e-book on integrating medical, pharmacy, and behavioral health benefits to manage total cost of care.
- **2026-01** — Elevance reported CarelonRx full-year 2025 operating revenue of $43.4 billion and operating gain of $2.418 billion.

## Links

- Website: https://www.carelonrx.com/
- LinkedIn: https://www.linkedin.com/company/carelonrx
- Twitter/X: https://twitter.com/carelonrx

---

Profile page: https://yespress.io/carelonrx
Published by YesPress — https://yespress.io
Last updated: 2026-10-21